Skip to content

Public FDA record

Z-1511-2018: Flex Arm Product Usage: The Synthes Flex Arm is a component of the Synthes Minimally Invasive Support Sy

Recall record Z-1511-2018 for Synthes, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1511-2018
Company in FDA record
Synthes, Inc.
FDA record creation date
Apr 24, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Quick connect feature of instruments may be unable to connect to the male features of Flex Arm Adaptors, Insight Retractors, or other mating parts.

Source facts

Action
The firm sent an Urgent Product Recall letter dated March 21, 2018, to affected customers. The letter identified the affected product, problem and actions to be taken. For questions call 1-610-719-5450 or contact your DePuy Synthes Sales Consultant.
Initiated
2018-03-05
Root cause
Device Design
Terminated
2019-10-16
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, Switzerland and Japan
Recall number
Z-1511-2018
Recall status
Terminated
CDRH record ID
163263
FDA record created
2018-04-24
Recall event number
79763

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗